Cumulative incidence, risk factors, and management of atrial fibrillation in patients receiving ibrutinib

Atrial fibrillation (AF) has been reported in up to 16% of patients taking ibrutinib. Data regarding the management of AF in this patient population are limited, and stroke prevention poses a challenge because of increased risk of bleeding with ibrutinib treatment. Our study sought to describe the i...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Blood Adv
Hoofdauteurs: Wiczer, Tracy E., Levine, Lauren B., Brumbaugh, Jessica, Coggins, Jessica, Zhao, Qiuhong, Ruppert, Amy S., Rogers, Kerry, McCoy, Anli, Mousa, Luay, Guha, Avirup, Heerema, Nyla A., Maddocks, Kami, Christian, Beth, Andritsos, Leslie A., Jaglowski, Samantha, Devine, Steven, Baiocchi, Robert, Woyach, Jennifer, Jones, Jeffrey, Grever, Michael, Blum, Kristie A., Byrd, John C., Awan, Farrukh T.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: American Society of Hematology 2017
Onderwerpen:
Lymphoid Neoplasia
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5728342/
https://ncbi.nlm.nih.gov/pubmed/29296820
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2017009720
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items